MedTrace Logo

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

NCT04208451 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-12-24

No results posted yet for this study

Summary

In this study are included patients on hemodialysis with anemia (levels of Hemoglobin\<110). After baseline measurements tha patients take Standardized Aronia melanocarpa extract for one mont and then all measurements were repeated.

Conditions

  • Renal Disease
  • Dialysis; Complications
  • Anemia

Interventions

DIETARY_SUPPLEMENT

Alixir 400 Protect

During 30 days all patients take every day 30ml of Alixir 400 protect

Sponsors & Collaborators

  • Pharmanova d.o.o., Obrenovac, Serbia

    collaborator UNKNOWN

  • University of Kragujevac

    lead OTHER

Principal Investigators

  • Isidora Milosavljevic · Department of pharmacy, University of Kragujevac

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
37 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2019-10-01
Completion
2019-10-01

Countries

  • Serbia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04208451 on ClinicalTrials.gov